Related Experiment Video
Updated: Mar 7, 2026

Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
Improving adherence and outcomes in diabetic patients
Renu Joshi1, Disha Joshi1, Pramil Cheriyath1
1Department of Endocrinology, Pinnacle Health Hospitals, Harrisburg, PA, USA.
A new mobile app, PatientPartner, significantly improved medication adherence and lowered HbA1c levels in diabetes patients. This 12-minute intervention shows promise for managing diabetes care effectively.
Area of Science:
- Digital Health
- Behavioral Science
- Endocrinology
Background:
- Diabetes nonadherence leads to significant healthcare costs and preventable mortality.
- Current adherence interventions are often expensive and yield suboptimal results.
Purpose of the Study:
- To evaluate the efficacy of a novel iOS application, PatientPartner, in improving diabetes self-management.
- To assess the impact of a complexity theory-derived app on patient adherence and glycemic control.
Main Methods:
- A randomized controlled trial involving 107 severely non-adherent diabetes patients (HbA1c >8).
- Intervention group used the 12-minute PatientPartner app focusing on information management, stress coping, and health strategies.
- Control group received standard care; both groups received weekly calls for 3 weeks. HbA1c was measured at baseline and 3 months.
Main Results:
- The intervention group demonstrated significant improvements in medication adherence (57%-96%), diet (50%-75%), and exercise (29%-43%) at 3 weeks.
- At 3 months, the intervention group's mean HbA1c decreased from 10.7 to 9.6.
- The control group showed no significant changes in any measured parameters.
Conclusions:
- A single, brief use of the PatientPartner app led to noteworthy improvements in diabetes self-management behaviors and glycemic control.
- This study provides the first randomized controlled trial evidence that a mobile application can positively impact HbA1c, a key biomarker for diabetes.
- The findings suggest that digital health interventions can be a cost-effective tool for enhancing diabetes care adherence.
Related Concept Videos
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Diabetes Mellitus: Type 2 and Gestational
Oral Hypoglycemic Agents: Biguanides and Glitazones
Dipeptidyl Peptidase 4 Inhibitors
Insulin: Dosing Regimen and Adverse Effects
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...

